An analysis of supply chain strategies in the regenerative medicine industry—implications for future development
CW Teng, L Foley, P O'Neill, C Hicks - International Journal of Production …, 2014 - Elsevier
The pharmaceutical, biotechnology and life sciences industry was worth approximately US
$1 trillion in 2010, of which 73.2% was attributed to pharmaceuticals, 25% to biotechnology …
$1 trillion in 2010, of which 73.2% was attributed to pharmaceuticals, 25% to biotechnology …
An analysis of supply chain strategies in the regenerative medicine industry—Implications for future development
C Wei Teng, L Foley, P O'Neill… - International Journal of …, 2014 - econpapers.repec.org
The pharmaceutical, biotechnology and life sciences industry was worth approximately US
$1 trillion in 2010, of which 73.2% was attributed to pharmaceuticals, 25% to biotechnology …
$1 trillion in 2010, of which 73.2% was attributed to pharmaceuticals, 25% to biotechnology …
An analysis of supply chain strategies in the regenerative medicine industry—Implications for future development
CW Teng, L Foley, P O'Neill, C Hicks - International Journal of Production …, 2014 - infona.pl
The pharmaceutical, biotechnology and life sciences industry was worth approximately US
$1 trillion in 2010, of which 73.2% was attributed to pharmaceuticals, 25% to biotechnology …
$1 trillion in 2010, of which 73.2% was attributed to pharmaceuticals, 25% to biotechnology …
An analysis of supply chain strategies in the regenerative medicine industry-Implications for future development
CW Teng, L Foley, PJ O'Neill… - International Journal of …, 2014 - research.monash.edu
The pharmaceutical, biotechnology and life sciences industry was worth approximately US 1
trillion in 2010, of which 73.2 was attributed to pharmaceuticals, 25 to biotechnology and the …
trillion in 2010, of which 73.2 was attributed to pharmaceuticals, 25 to biotechnology and the …
An analysis of supply chain strategies in the regenerative medicine industry—Implications for future development
C Wei Teng, L Foley, P O'Neill, C Hicks - International Journal of …, 2014 - ideas.repec.org
The pharmaceutical, biotechnology and life sciences industry was worth approximately US
$1 trillion in 2010, of which 73.2% was attributed to pharmaceuticals, 25% to biotechnology …
$1 trillion in 2010, of which 73.2% was attributed to pharmaceuticals, 25% to biotechnology …
An analysis of supply chain strategies in the regenerative medicine industry-Implications for future development
CW Teng, L Foley, P O'Neill, C Hicks - International Journal of …, 2014 - eprints.ncl.ac.uk
The pharmaceutical, biotechnology and life sciences industry was worth approximately US
$1 trillion in 2010, of which 73.2% was attributed to pharmaceuticals, 25% to biotechnology …
$1 trillion in 2010, of which 73.2% was attributed to pharmaceuticals, 25% to biotechnology …